ES2104985T3 - Derivados de butadieno, su preparacion y utilizacion como agente antitrombotico. - Google Patents

Derivados de butadieno, su preparacion y utilizacion como agente antitrombotico.

Info

Publication number
ES2104985T3
ES2104985T3 ES93104977T ES93104977T ES2104985T3 ES 2104985 T3 ES2104985 T3 ES 2104985T3 ES 93104977 T ES93104977 T ES 93104977T ES 93104977 T ES93104977 T ES 93104977T ES 2104985 T3 ES2104985 T3 ES 2104985T3
Authority
ES
Spain
Prior art keywords
group
formula
substituted
derivatives
lower alkoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93104977T
Other languages
English (en)
Inventor
Tameo Iwasaki
Takashi Nishitani
Akio Ohtani
Masanori Inamasu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tanabe Seiyaku Co Ltd
Original Assignee
Tanabe Seiyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP4119481A external-priority patent/JP2541421B2/ja
Priority claimed from JP4119480A external-priority patent/JP2541420B2/ja
Priority claimed from JP4119482A external-priority patent/JP2564781B2/ja
Priority claimed from JP4119483A external-priority patent/JP2595931B2/ja
Application filed by Tanabe Seiyaku Co Ltd filed Critical Tanabe Seiyaku Co Ltd
Application granted granted Critical
Publication of ES2104985T3 publication Critical patent/ES2104985T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/225—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C235/34—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • C07C243/24—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids
    • C07C243/26—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C243/30—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of an unsaturated carbon skeleton
    • C07C243/32—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of an unsaturated carbon skeleton the carbon skeleton containing rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Financial Or Insurance-Related Operations Such As Payment And Settlement (AREA)
  • Reinforced Plastic Materials (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Materials For Medical Uses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)

Abstract

NUEVOS DERIVADOS DEL BUTADIENO DE LA FORMULA [I]: EN DONDE EL ANILLO A ES UN ALCOXIFENILO TRI-INFERIOR, R1 Y R2 SE COMBINAN UNO CON OTRO PARA FORMAR UN GRUPO DE LA FORMULA: N-R3 O UNO DE R1 Y R2 ES ALCOXI INFERIOR, Y EL OTRO ES UN GRUPO DE LA FORMULA: -NHR3, EN LA QUE R3 ES HIDROGENO, ALQUILO INFERIOR SUSTITUIDO O INSUSTITUIDO, ALCOXI INFERIOR SUSTITUIDO O INSUSTITUIDO, AMINO SUSTITUIDO O INSUSTITUIDO, HIDROXI O PIRIDILOCARBONILO, O SALES DE LOS MISMOS. ENTRE LOS DERIVADOS DEL BUTADIENO DESEADOS [I] DE LA PRESENTE INVENCION, LOS COMPUESTOS DEL TIPO DE ACIDO BUTENOICO 3, DE POR SI TIENEN ACTIVIDAD ANTITROMBOTICA, PERO TAMBIEN PUEDEN SER USADOS COMO UN INTERMEDIO PARA LA PREPARACION DE COMPUESTOS DEL TIPO 2,5-PIRROLIDINEDIONA QUE TIENEN EXCELENTE ACTIVIDAD ANTITROMBOTICA. Y ADICIONALMENTE UN ESTER DEL ACIDO BUTENOICO DE LA FORMULA [II]: EN DONDE EL ANILLO A ES UN GRUPO ALCOXIFENILO TRI-INFERIOR Y UNO DE R12 Y R22 ES UN GRUPO ALCOXI INFERIOR Y EL OTRO ES UN GRUPO HIDROXI, O SALES DE LOS MISMOS, COMO INTERMEDIO SINTETICO.
ES93104977T 1992-03-26 1993-03-25 Derivados de butadieno, su preparacion y utilizacion como agente antitrombotico. Expired - Lifetime ES2104985T3 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP4119481A JP2541421B2 (ja) 1992-03-26 1992-03-26 ３−ブテン酸誘導体及びその製法
JP4119480A JP2541420B2 (ja) 1992-03-26 1992-03-26 ３−ブテン酸誘導体及びその製法
JP4119482A JP2564781B2 (ja) 1992-03-26 1992-03-26 ２，５−ピロリジンジオン誘導体及びその製法
JP4119483A JP2595931B2 (ja) 1992-03-26 1992-03-26 ２，５−ピロリジンジオン誘導体及びその製法

Publications (1)

Publication Number Publication Date
ES2104985T3 true ES2104985T3 (es) 1997-10-16

Family

ID=27470596

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93104977T Expired - Lifetime ES2104985T3 (es) 1992-03-26 1993-03-25 Derivados de butadieno, su preparacion y utilizacion como agente antitrombotico.

Country Status (11)

Country Link
US (2) US5514815A (es)
EP (1) EP0563798B1 (es)
CN (1) CN1078720A (es)
AT (1) ATE154344T1 (es)
AU (1) AU658271B2 (es)
DE (1) DE69311419T2 (es)
DK (1) DK0563798T3 (es)
ES (1) ES2104985T3 (es)
FI (1) FI931346A (es)
GR (1) GR3023808T3 (es)
IL (1) IL105124A0 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY118876A (en) 1996-03-29 2005-02-28 Tanabe Seiyaku Co Butadiene derivatives and process for preparing thereof
US20030068375A1 (en) 2001-08-06 2003-04-10 Curtis Wright Pharmaceutical formulation containing gelling agent
LT1765292T (lt) 2004-06-12 2018-01-10 Collegium Pharmaceutical, Inc. Nuo piktnaudžiavimo apsaugotos vaistų formos
US8853257B2 (en) 2005-11-21 2014-10-07 Mordechai Sharir Succinimide derivatives as ocular hypotensive agents
WO2007057889A2 (en) * 2005-11-21 2007-05-24 Mordechai Sharir Succinimide derivatives as ocular hypotensive agents
JP5213855B2 (ja) 2007-06-27 2013-06-19 興和株式会社 ピラゾロン誘導体
US10668060B2 (en) 2009-12-10 2020-06-02 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
CN103370058A (zh) 2010-12-22 2013-10-23 普渡制药公司 包覆的抗篡改控制释放剂型
KR101458334B1 (ko) 2010-12-23 2014-11-04 퍼듀 퍼머 엘피 탬퍼 저항성 고체 경구 투여 형태
US10751287B2 (en) 2013-03-15 2020-08-25 Purdue Pharma L.P. Tamper resistant pharmaceutical formulations
US9737530B1 (en) 2016-06-23 2017-08-22 Collegium Pharmaceutical, Inc. Process of making stable abuse-deterrent oral formulations
CN108059598A (zh) * 2016-11-08 2018-05-22 华东理工大学 由巴豆酸衍生物制备多取代二烯烃的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4145536A (en) * 1973-09-01 1979-03-20 Heller Harold G Photochromic compounds
GB1442628A (en) * 1973-09-01 1976-07-14 Heller H G Photochromic compounds
US4182629A (en) * 1973-09-01 1980-01-08 Heller Harold G Photochromic compounds
GB2104504B (en) * 1981-07-16 1985-05-09 English Clays Lovering Pochin Stabilisation of photochromic fulgides and fulgimides
JP2588013B2 (ja) * 1987-12-29 1997-03-05 吉富製薬株式会社 ブタジエン化合物およびその医薬用途
DE69023865T2 (de) * 1989-07-28 1996-10-17 Wako Pure Chem Ind Ltd Fulgimidderivate.

Also Published As

Publication number Publication date
ATE154344T1 (de) 1997-06-15
EP0563798B1 (en) 1997-06-11
FI931346A0 (fi) 1993-03-26
CN1078720A (zh) 1993-11-24
IL105124A0 (en) 1993-07-08
EP0563798A1 (en) 1993-10-06
DE69311419D1 (de) 1997-07-17
DE69311419T2 (de) 1997-11-06
US5514815A (en) 1996-05-07
AU3525093A (en) 1993-09-23
GR3023808T3 (en) 1997-09-30
US5639789A (en) 1997-06-17
AU658271B2 (en) 1995-04-06
FI931346A (fi) 1993-09-27
DK0563798T3 (da) 1997-07-07

Similar Documents

Publication Publication Date Title
AU586839B2 (en) Substituted imidazole derivatives and their preparation and use
ES2104985T3 (es) Derivados de butadieno, su preparacion y utilizacion como agente antitrombotico.
IL88303A (en) Derivatives of 6-fluoro-7-û4-( (5-methyl-2-oxo-1,3- dioxolen-4-yl)methyl) piperazin-1-ylù-4 (1h)-oxo-1,3-thiazeto(3,2-a) quinoline-3-carboxylic acid
NZ214156A (en) Quindone derivatives and pharmaceutical compositions
IL77717A (en) Pharmaceutical compositions containing derivatives of imidazole,their preparation and some novel compounds of this type
ES8606330A1 (es) Procedimiento para preparar derivados de acidos quinolincar-boxilicos
AU585981B2 (en) Benzo (IJ) quinolizine-2-carboxylic acid derivatives, the salts and their hydrates, pharmaceutical compositions thereof, and processes for preparing the same
IE873442L (en) Cephalosporin derivative
ES2059451T3 (es) Derivados de naftotiazepina y su procedimiento de preparacion.
MY101746A (en) 1,5-benzothiazepine derivatives, a process for preparing the same, pharmaceutical compositions as well as the use thereof.
ES8307812A1 (es) Un procedimiento para la preparacion de nuevos amidin derivados del acido clavulawilo.
KR940002252A (ko) 우수한 항균작용을 갖는 신규한 피리돈 카르복실산 유도체 및 그의 제조방법

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 563798

Country of ref document: ES